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1.   INTRODUCTION 
 
The last century has witnessed the epidemiologic transition among many populations, 
which has resulted in a decrease in infectious disease, with a concomitant increase in 
chronic noncommunicable diseases, such as cardiovascular disease, cancer, and diabetes.3 
At any given time, different countries in the world or even different regions within a 
country are at different stages of the epidemiologic transition. In developing countries 
like India, the increased incidence of noncommunicable diseases adds to the continuing 
burden of infectious, nutritional, and perinatal diseases, which has been termed the 
double-burden of diseases. 2 
 
Type 2 Diabetes, a global public health problem, is now emerging as a pandemic2. 
Prevalence of diabetes in adults worldwide was estimated to be 4.0% in 1995 and to rise 
to 5.4% by the year 2025.1  Much of this increase in diabetes will occur in developing 
countries, due to population growth, ageing, unhealthy diets, obesity and sedentary 
lifestyles. Thus, by the year 2025, 75% of people with diabetes will reside in developing 
countries, as compared with 62% in 19951. In developed countries, most people with 
diabetes are above the age of retirement. In developing countries, those most frequently 
affected are in the middle, productive years of their lives, aged between 35 and 64.1                                     
 India has highest prevalence of diabetes among Asian countries.1, 2 It is estimated 
that there are approximately 33 million adult currently with diabetes in India. This 
number is likely to increase to 57.2 million by the year 2025.2 A large number of cross- 
 sectional studies are reported in different states of India19, 31, 32 but there are no incidence 
studies done in India to estimate annual risk of new cases.  
Many of the estimated numbers and percentages of people with diabetes in India 
were derived by applying diabetes prevalence estimates to the population1. Prevalence 
estimates are most useful for assessing the most general impact of a health condition and 
for estimating the medical and supportive care needs of people likely to be affected by it. 
The prevalence of a given condition will depend both on the rate of new cases and on 
how long people live with the condition. 4.  Survival with a health condition, in turn, 
depends on available treatments, the rate at which the disease progresses, whether 
treatments are appropriately applied, other health conditions a person may face and 
environmental supports. Because of these features, prevalence studies are not ideal for 
studying new occurrence of disease and its risk factor.  
  Gathering Informations based on incidence is the ideal method for studying 
disease occurrence because it involves collecting and analyzing all the relevant 
information on the source population, and we can get better information on when 
exposure and disease occurred. Because it is limited to new cases, differences in 
incidence between populations indicate differences in risk, and hence point to factors 
(i.e., differences between the populations) that lower or elevate risk. 4 Monitoring of 
national trends in the prevalence and incidence of NIDDM were needed so that the 
burden of diabetes can be assessed, the impact of risk factors can be described and 
interventions can be developed 
The natural history of progression from normal glucose tolerance (NGT) to  type 
2 diabetes is   not well defined.26 Understanding the natural history of type 2 diabetes is 
essential for early detection of prediabetic hyperglycemia and for interrupting the 
progression from normal to abnormal glucose tolerance. A number of longitudinal studies 
 reported that people having pre diabetes are at a higher risk of developing diabetes and 
cardiovascular complications.  38 No longitudinal studies are available in India to estimate 
the risk of prediabetes stage in future diabetes. 
 This study is under taken as a follow up of a part of the ICMR-CMC study on 
CHD –prevalence  and risk factors that was done in 1991-1993 to find out the whether 
baseline fasting blood sugar is a significant  predictor of future diabetes or not. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
2. JUSTIFICATION 
Type 2 Diabetes melitus is a chronic disease that affects the lives of millions of 
people. It is occurring in epidemic proportions worldwide.2,3 The regions with the greatest 
potential increases are Asia and Africa, where diabetes rates could rise to 2 or 3 times 
those experienced today. 3 In Asia alone an estimated 85 million were affected; this 
continent had both the highest proportion of current cases and the greatest projected 
increases for the future. 1 
Very high levels of diabetes have been reported in urban areas of India,29,31,32,33 
but few data are available for rural regions where >70% of the population lives.21 Data 
from a new large-scale survey done in 2005 suggest rural India may soon experience the 
same epidemic of diabetes. According to a cross-setional study in rural area of Andhra 
Pradesh on the basis of the finger-prick measurements, the prevalence of diabetes was 
13.2% (95% CI 12.1–14.3), of which 6.4% (5.6–7.2) were known and 6.8% (5.9–7.6) 
were previously undiagnosed. 19 
 Several cross sectional studies have been carried out in India30, 31, 32, 33 about the 
prevalence of type 2diabetes but there are no longitudinal studies for incidence. 
Longitudinal studies involve lengthy periods of follow-up and many resources in terms of 
both time and funding, and it may be difficult to dofor practical reasons.  
Why are these trends alarming?  Once diabetes develops, the cost of caring for 
patients is prohibitive. Poorly managed diabetes leads to several complications (e.g., end-
stage renal failure, blindness, amputation and heart disease) that many developing 
countries are ill equipped to tackle. In addition, the burden on individuals and on society 
extends past human suffering to include staggering economic costs, lost productivity, and 
 social capital.45 So aggressive efforts must be directed toward primary prevention of 
diabetes in developing countries. 
Development of type 2 diabetes is to some extent a predictable event. For 
prevention purposes, there is great interest in the identification of persons at high risk for 
developing diabetes. Several longitudinal and retrospective community-based studies 
have been conducted by independent researchers in different parts of world to estimate 
the incidence of type 2 diabetes and its predictors.10, 26, 37, 38The correlation of a risk 
factor(s) with development of diabetes is never 100%. 
A commonly accepted entity and one of much concern is the prediabetes state11 
Epidermiological studies on the progression of disease have brought to light the 
importance of this state. American diabetes association (ADA) and World Health 
Organization (WHO) have recently introduced impaired fasting glucose (IFG; fasting 
plasma glucose level 6.1–6.9 mmol/l or 110-125mg/dl) as a category of intermediate 
glucose metabolism.5, 6, 7 The relationships between impaired fasting glucose and type2 
diabetes have never clearly investigated. A number of longitudinal studies from western 
countries reported different lower limit for impaired fasting glucose that can predict the 
future diabetes.37,38 Still sufficient datas are lacking from Indian studies to identify the 
ideal lower limit of fasting blood sugar that predicts future diabetes. 
This is a nonconcurrent cohort study on predictive validity of fasting blood 
glucose in future diabetes in a rural block in Tamil Nadu. In addition to estimating 
predictive validity of fasting glucose in future diabetes, other selected risk factors are also 
studied.  
 
 
 
  
 
3. AIM AND OBJECTIVES 
 
AIM  
To estimate the predictive validity of fasting plasma glucose in risk of future type 2 
diabetes in a rural south Indian population aged 30-60 years over time. 
 
OBJECTIVES 
.  1. To determine the risk`of progression from normoglycemia to type 2 diabetes 
based on the fasting plasma glucose (FPG) concentration among a cohort of rural people 
aged 30-60 years in Kaniyambadi block over a period of 15 years. 
2. To measure association of selected risk factors and the probability of 
developing type 2 diabetes mellitus in Kaniyambadi block over a period of 15 years. 
 
 
 
 
 
 
   
 4. REVIEW OF LITERATURE 
4.1   Introduction 
Diabetes is a chronic condition that occurs when the pancreas does not produce 
enough insulin or when the body cannot effectively use the insulin, it produces. 
Hyperglycaemia and other related disturbances in the body’s metabolism can lead to 
serious damage to many of the body’s systems, especially the nerves and blood vessels.18 
There are two basic forms of diabetes: 
• Type 1: people with this type of diabetes produce very little or no insulin. People 
with type 1 diabetes require daily injections of insulin to survive. 
• Type 2: people with this type of diabetes cannot use insulin effectively. People 
with type 2 diabetes can sometimes manage their condition with lifestyle measures alone, 
but oral drugs are often required, and less frequently insulin, in order to achieve good 
metabolic control. 
Most people with diabetes have type 2. Many of them have no symptoms and are 
only diagnosed after many years of onset. 18 
4.2 Complications associated with diabetes mellitus18 
Cardiovascular disease is responsible for between 50% and 80% of deaths in 
people with diabetes. 
Risk factors for heart disease in people with diabetes include high blood pressure, 
high serum cholesterol, obesity and smoking. Recognition and management of these 
conditions may delay or prevent heart disease in people with diabetes. 
• Diabetic neuropathy is probably the most common complication. Studies suggest 
that up to 50% of people with diabetes are affected to some degree. Major risk factors of 
this condition are the level and duration of elevated blood glucose. Neuropathy can lead 
 to sensory loss and damage to the limbs. It is also a major cause of impotence in diabetic 
men. 
• Diabetic retinopathy is a leading cause of blindness and visual disability. 
Research findings suggest that, after 15 years of diabetes, approximately 2% of people 
become blind, while about 10% develop severe visual handicap. 
• Diabetes is among the leading causes of kidney failure, but its frequency varies 
between populations and is also related to the severity and duration of the disease. 
• Diabetic foot disease, due to changes in blood vessels and nerves, often leads to 
ulceration and subsequent limb amputation. Diabetes is the most common cause of non-
traumatic amputation of the lower limb. 
4.3 Pathology of diabetes18 
Several pathogenic processes are involved in the development of diabetes. These 
range from autoimmune destruction of the ß-cells of the pancreas with consequent insulin 
deficiency to abnormalities that result in resistance to insulin action. The basis of the 
abnormalities in carbohydrate, fat, and protein metabolism in diabetes is deficient action 
of insulin on target tissues. Deficient insulin action results from inadequate insulin 
secretion and/or diminished tissue responses to insulin at one or more points in the 
complex pathways of hormone action. Impairment of insulin secretion and defects 
iinsulin action frequently coexist in the same patient, and it is often unclear which 
abnormality is the primary cause of the hyperglycaemia 
4.4 Global burden of type 2 diabetes 
 
 
 
  
 
Figure 4.1 
Global diabetes prevalence by age and sex for 2000 
 
Source: Global Prevalence of Diabetes Estimates for the year 2000 and projections for 2030 
Diabetes Care 27:1047-1053, 2004 
A diabetes epidemic is underway. Between 1995 and 2025 there will be a 35% 
increase in the worldwide prevalence of diabetes, from 4.0 to 5.4%.1 Prevalence is higher 
in developed than in developing countries and will remain so in 2025. 1 In developed 
countries, the increase in prevalence will be 27%, from 6.0 to 7.6%. In developing 
countries, the increase will be 48%, from 3.3 to 4.9% between 1995 and 2025. The 
highest increases in prevalence will be for China (68%) and India (59%). 1Quantifying 
the prevalence of diabetes and the number of people affected by diabetes, now and in the 
future, is important to allow rational planning and allocation of resources. 
The age structure of the diabetic populations of developed and developing 
countries are markedly different. For the developed countries, the oldest age group has 
 the largest number of people with diabetes in 1995 and will experience the greatest 
increase in numbers by the year 2025. 1 However, for the developing countries, the 45- to 
64-year-old age group contained the largest number of people with diabetes in 1995, and 
this tendency will be further accentuated by the year 2025. The age structure of the world 
total follows the trend for developing countries. 
4.5 Male/female diabetes ratio 
For 1995 for the world as a whole, there were more women than men with 
diabetes (73 vs. 62 million1. The female excess is pronounced in the developed countries 
(31 vs. 20 million), but in the developing countries, there are equal numbers of men and 
women with diabetes (42 million in each case). By the year 2025, the worldwide 
female/male excess is estimated to be reduced somewhat (to 159 vs. 141 million).1 
4.6 Urban rural difference 
For developing countries as a whole, the urban/rural ratio in diabetes frequency is 
predicted to rise from 1.6 in 1995 to 3.3 in 20251.By 2025, there will be a considerable 
excess of diabetes in the urban areas. 
4.7 Type2 diabetes –major health problem in India  
Epidemiological studies among migrant Asian Indians in many countries showed 
higher prevalence of type 2 diabetes compared with the host populations and other 
migrant ethnic group34 
India is facing an epidemic of type 2 diabetes,2,3,24,55 with high prevalence in 
urban areas 29 .One  fourth of the adult population in India is either already diabetic or 
ready to get it anytime (World Diabetes Foundation). By 2025, there will be three fold 
excess in urban areas. Male/female diabetes ratio in India is 1.3 (11 vs. 8 million). By 
2025 male excess will, decrease in India. 2 Previous studies shows that South-Asian 
 ethnicity is associated with multiple risk factors for type 2 diabetes and CVD 51 
Epidemiological studies among migrant Asian Indians in many countries showed higher 
prevalence of type 2 diabetes compared with the host populations and other migrant 
ethnic groups 2  
4.8 Trends and burden in urban India 
Studies conducted in India in the last decade have highlighted that not only isthe 
prevalence of type 2 diabetes high, but also that it is increasing rapidly in the urban 
population (Fig4.2) 
Survey conducted in 1988-1989, in the city of Madras, south India, showed that 
the prevalence of diabetes mellitus in adults was 8.2% and prevalence of impaired 
glucose tolerance (IGT) was 8.7%.31. Another cross-sectional study conducted 5 years 
later in the same urban area age-standardized prevalence of diabetes had increased 
to11.6% from 8.2% in 1989 and IGT was 9.1%, similar to 8.7% in 198931. In the peri 
urban study group, the age-standardized prevalence of Type 2 diabetes was 5.9%, which  
fig 4.2 
 
 
 
Year 1970’s 1980’s 1990’s 2000 2005 
Study/Place ICMR Tenali New Delhi NUDS CURES 
Author Ahuja Murthy Ahuja Ramachandran Mohan 
2.3
4.7
6.7
12.5
15.5
0
2
4
6
8
10
12
14
16
pr
ev
al
en
ce
(%
)
1970 1980 1990 2000 2005
year of the  study
Prevalence of diabetes in urban India(1971-2005)
  
 
was intermediate to that in the urban (11.6%) and rural (2.4%) populations. 
 
 
 
4 .9 Burden in rural area 
India has nearly 33 million diabetic subjects today. A wide urban-rural difference 
in the rates of prevalence of diabetes was evident in the last decade (a four-fold 
difference). Now,the impact of urbanisation is being felt in the rural population, which 
has also resulted in changes in their lifestyle. As a consequence there is an increase in the 
prevalence of diabetes in the rural population, too (from 2.2 per cent to 6.4 percent44 
There is also an increasing incidence of impaired glucose tolerance (IGT) in both the 
rural and urban population.  
. A cross-sectional population survey was undertaken to determine the prevalence 
of diabetes mellitus (DM) and impaired glucose tolerance (IGT) in subjects aged 25 years 
and above in India.59The standardized prevalence rate for DM in the total Indian, urban 
and rural populations was 4.3, 5.9 and 2.7%, respectively. The corresponding IGT rates 
in the three populations were 5.2, 6.3 and 3.7%, respectively. The scenario is changing 
rapidly due to socio-economic transition occurring in the rural areas 
Since most of the prevalence, studies of India were concentrated in urban areas, 
sufficient data is lacking from the rural areas. A study on the prevalence and management 
of diabetes in rural India, found 13 per cent of adults aged 30 or older have the disease, 
with a further 16 per cent exhibiting features of pre-diabetes. The study sampled more 
 than 4,500 people in rural areas of Andhra Pradesh19. The findings reflect the rapidly 
changing nature of health problems across India, even in remote rural aeas. Another 
major concern is since majority of Indian population is living in rural areas even small 
increase in prevalence in rural area will create significant burden on Indian health system. 
4.10.  Economic costs of diabetes 
 Because of its chronic nature, the severity of its complications and the means 
required to control them, diabetes is a costly disease, not only for affected individuals and 
their families, but also for the health systems. 
  Studies in India estimate that, for a low-income Indian family with an adult with 
diabetes, as much as 25% of family income may be devoted to diabetes care. Diabetic 
epidemic in India likely to trim approximately 1 per cent from the country's gross 
domestic product.. However, the full burden of diabetes is hard to measureas as death 
records often fail to reflect the role of diabetes in diagnosis.of cause of death. 
4.11 Diagnositic criteria for type 2 diabetes 5,6,7,8,9 
In 1997, an International Expert Committee5 was convened to re examine the 
classification and diagnostic criteria of diabetes, which were based on the 1979 
publication of the National Diabetes Data Group and subsequent WHO study 
grou.Because of its deliberations, the Committee recommended several changes to the 
diagnostic criteria for diabetes and for lesser degrees of impaired glucose regulation 
(IFG/IGT) 7 .The following were the major changes or issues addressed. The major 
change recommended in the diagnostic criteria for diabetes mellitus were5 
1. The use of fasting plasma glucose (FPG) test for the diagnosis of diabetes. 
2. Lowering of the diagnostic value of the fasting plasma glucose concentration to 7.0 
mmol l-1 (126 mg dl-1) and above from the former level of 7.8 mmol l-1 (140 mg dl-1) and 
 above. 
For whole blood the proposed new level is 6.1 mmol l-1 (110 mg dl-1) and above, 
12 from the former 6.7 mmol l8(120 mg dl-1). The WHO adopted this lower cut off point 
for FPG in 1999. The WHO-1999 criteria differ from the ADA criteria by still taking into 
account the post load glucose levels. Because the ADA criteria are based on fasting 
plasma glucose (FPG) values only, and the cut off point for the diagnosis of diabetes has 
been lowered to 126 mg/dL (7.0 mmol/L) (the cut off point of the WHO-1985 criteria is 
140 mg/dL [7.8 mmol/L]),it is of importance to know how this affects the incidence of 
diabetes. 
 
 
4.12 Rationale for the revised criteria for diagnosing diabetes  
The revised criteria for diagnosing diabetes are based primarily on longitudinal studies 
demonstrating the presence of micro vascular and macro vascular complications at these 
lower glucose concentrations 61 In addition, the 1985 WHO diagnostic criterion for 
diabetes based on fasting plasma glucose level 140mg/dl represents a greater degree of 
hyperglycaemia than the criterion based on plasma glucose level two hours after a 75 g 
glucose load 200mg/dl.8 A fasting plasma glucose level of>=126mg/dl accords more 
closely with this 2 h post-glucose.of hyperglycaemia than did the cut point of 2-h PG 
200 mg/dl (11.1 mmol/l27 
 
 
 
  
Table  4.1 new WHO criteria for diagnosis of diabetes mellitus  
 
GLUCOSE CONCENTRATION, MMOL L/1 (MG DL/1) 
  Whole blood 
Whole blood 
Plasma* 
  Venous Capillary Venous 
Diabetes Mellitus:    
 Fasting >=6.1 (>=110) >=6.1 (>=110) >=7.0 (>=126) 
  
Source WHO: definition, diagnosis and classification of diabetes mellitus andits 
complication. Report of a WHO consultation part 1 diagnosis and classification of 
diabetes mellitus Geneva, world h1999 
4.13 Advantages of fasting plasma glucose over oral glucose tolerance 
test 
1. Reproducibility –a property for, which the FPG appears to be preferable.40 
When OGTT were repeated in adults during a 2 to 6 week interval, the intra-individual 
coefficients of variation were 6.4% for the FPG and 16.7% for the 2-h PG.  19 For the men 
in the Paris Prospective study38 in whom diabetes was diagnosed at baseline, 58% 
diagnosed by FPG were still considered diabetic after 30 months of follow-up, Therefore, 
as expected, diabetes diagnosed by FPG was more stable40.  The San Antonio group 
reported that patients diagnosed with diabetes exclusively based on the 2-hr PG were five 
 or    
 2-h post glucose load >=10.0 (>=180) >=11.1 (>=200) >=11.1 (>=200) 
 or both    
Impaired Glucose Tolerance (IGT):    
 Fasting (if measured) <6.1 (<110) <6.1 (<110) <7.0 (<126) 
 and    
 2-h post glucose load >=6.7 (>=120) and 
>=7.8 (>=140) 
and >=7.8 (>=140) and 
 <10.0 (<180) <11.1 (<200) <11.1 (<200) 
Impaired Fasting Glycaemia (IFG):    
 Fasting >=5.6 (>=100) and 
>=5.6 (>=100) 
and >=6.1 (>=110) and 
 <6.1 (<110) <6.1 (<110) <7.0 (<126) 
 and (if measured)    
 2-h post glucose load <6.7 (<120) <7.8 (<140) <7.8 (<140) 
 times more likely to revert to non diabetic status after 7–8 years of follow-up than those 
meeting the 126 mg/dl FPG diagnostic criteria 
2. The measurement of FPG is less expensive and less intrusive than the 2-hr PG. 
Although both tests require overnight fasting for at least 8 h, the 2-h PG frequently results 
in an extended office visit for the patient, potentially resulting in more lost wages or an 
inability to engage in other desired activities 
3. A minority of patients cannot tolerate the glucose challenge drink, making the 
results of the test uninterruptible because the full glucose load was not ingested. 
4.14 Disadvantages of FPG 
Some patients will not have actually fasted, potentially resulting in a falsely 
elevated FPG, whereas the impact of non fasting on the 2-h PG value may be less. 
4.15 Prediabetes 11 
The term ‘prediabetes’ has been used to describe the condition in which blood 
glucose levels are higher than normal but not yet diabetic and includes the two 
abnormalities, impaired glucose tolerance (IGT) and impaired fasting glucose (IFG)4.16 
Impaired fasting glucose7 (IFG) 
This stage includes individuals with fasting glucose levels 110 mg/dl (6.1 
mmol/l) but <126 mg/dl (7.0 mmol/l) (IFG). In 1997 and 1999, American Diabetes 
Association and the WHO respectively added the term impaired fasting glucose 
4.17 Impaired glucose tolerance. 7(IGT) 
People whose FPG was <126 mg/dl but whose 2-h PG after a 75-g oral glucose 
challenge was 140–199 mg/dl.  The FPG and 2-h PG are both single point-in-time 
measures of glycaemia. Both are associated with adverse outcomes that result from 
chronic hyperglycaemia. Although they are not interchangeable, since the FPG alone does 
 not always detect people with IGT and the 2-h PG does not always detect people with 
IFG, both tests are useful in terms of their ability to detect hyperglycaemia and the 
consequences of disordered glucose metabolism. 
4.18 Pathophysiology of Prediabetes 11 
Normal control of FG depends on the ability to maintain adequate basal insulin 
secretion, and on appropriate levels of insulin sensitivity in the liver to control hepatic 
glucose output. Abnormalities of these metabolic functions characterise IFG. Defects of 
insulin secretion are often evident in IFG, whereas impaired insulin sensitivity may be 
more apparent in IGT. Individuals with isolated IFG and isolated IGT showed similar 
impairments in insulin action, but those with isolated IFG have a more pronounced defect 
in early insulin secretion and, in addition, increased endogenous glucose output. More 
severe metabolic abnormalities are present in individuals with combined IFG and IGT. 
Data from the RIAD study demonstrated that isolated IFG and isolated IGT show 
differences in the degree of insulin resistance and anomalies of insulin secretion: subjects 
with IGT exhibit a deficit in the early and late phases of insulin secretion, but this study is 
limited by its cross-sectional design. 
4.19 Importance of Impaired fasting glucose 
The category IFG was introduced to designate the zone between the upper limit of 
normal FPG and the lower limit of diabetic FPG,5 much as IGT designates the zone 
between the upper limit of normal 2-h PG and the lower limit of diabetic 2-h PG.IGT and 
IFG are not clinical entities in their own right, but rather risk categories for future 
diabetes and cardiovascular disease63, 64, 65.  Such subjects, like those with IGT, have 
increased risks of progressing to diabetes and macro vascular disease. Although 
prospective data are sparse and early available data suggest a lower risk of progression 
than IGT, although a similar CVD risk factor profile has been shown in subjects impaired 
 fasting glucose (IFG; fasting plasma glucose level 6.1–6.9 mmol/l) can predict future 
type 2 diabetes as accurately as does impaired glucose tolerance is still not clear. Some of 
the longitudinal population-based studies demonstrate the higher sensitivity of IGT over 
IFG for predicting progression to type 2 diabetes.  Screening by the criteria for IFG alone 
would identify fewer people who subsequently progress to type 2 diabetes than would the 
oral glucose tolerance test.38, 66, 67 Data from theHoorn study showed  that the risk of 
diabetes does increase markedly at FPG concentrations above 100 mg/dl. 63  
The Paris Prospective study38 reported that the risk of developing diabetes over 
three years was greater among middle aged men with fasting blood glucose>6.1than it 
was for a lower FPG. 
4.20. Impact of lowering impaired fasting glucose from 110 mg/dl to 
100mg/dl 
The Expert Committee on Diagnosis and Classification of Diabetes Mellitus 
recently recommended that the normal fasting glucose level should be adjusted 
downward from 110 to 100 mg/dl.  The advantages of this change as reported by the 
committee have been questioned. 62,65by a number of other studies. 
4.21 Risk factors for diabetes 66 
Specific population subgroups have a much higher prevalence of diabetes than the 
population as a whole. These subgroups have certain attributes or risk factors that either 
directly cause diabetes or are associated.  Several of the risk factors associated with 
diabetes are potentially modifiable     
Most of the risk factors of diabetes are explained in terms of metabolic 
syndrome.67The metabolic syndrome is a cluster of the most dangerous heart attack risk 
factors: diabetes and prediabetes, abdominal obesity, high cholesterol and high blood 
 pressure According  to the The International Diabetes Federation (IDF)), a person has the 
metabolic syndrome if they have central obesity (waist circumference > 94cm for 
Europid men and > 80cm for Europid women) plus any 2 of the following factors: 
increased triglyceride concentrations, reduced HDL cholesterol levels, increased blood 
pressure (systolic >130mmHg or diastolic >85mmHg), and increased fasting plasma 
glucose (>100mg/dL [5.6mmol/L]) or previously diagnosed type 2 diabetes. Definitions 
of obesity based on gender and ethnicity are provided( South Asians Male ≥ 90 
cmFemale ≥ 80 cm)   It also increases the risk of developing type 2 diabetes, if not 
already present, fivefold.67      
                                                                                    
Table 1— Risk factors for type 2 diabetes66 
 
Source ADA position statements on screening for diabetes type 2 diabetes care 
volume27suppliment 1 January 2004 
4.22 Risk factors for type2 diabetes mellitus – Indian population29 
India is facing an epidemic of type 2 diabetes, with high prevalence in urban 
areas. Urbanization and associated life style changes adversely affect the risk factors for 
AGE 45 YEARS 
OVERWEIGHT (BMI 25 KG/M2*) 
FAMILY HISTORY OF DIABETES (I.E., PARENTS OR SIBLINGS WITH 
DIABETES 
HABITUAL PHYSICAL INACTIVITY 
RACE/ETHNICITY (E.G., AFRICAN-AMERICANS, HISPANIC-AMERICANS, 
NATIVE AMERICANS, ASIAN-AMERICANS, AND PACIFIC ISLANDERS 
PREVIOUSLY IDENTIFIED IFG OR IGT 
HISTORY OF GDM OR DELIVERY OF A BABY WEIGHING >9 LBS 
HDL CHOLESTEROL 35 MG/DL (0.90 MMOL/L) AND/OR A TRIGLYCERIDE 
LEVEL 250 MG/DL (2.82 MMOL/L) 
POLYCYSTIC OVARY SYNDROME 
 
 diabetes unmasking the high genetic tendency existing in the population.28Various 
epidemiological studies in Indians have shown that the increasing prevalence of diabetes 
could be attributed to a high genetic risk and lower risk thresholds for acquired risk 
factors such as age, obesity,abdominal adiposity and a high percentage of body fat. 
The risk of diabetes increases with a body mass index (BMI) of >23 kg/m(2) and 
waist circumference of 85 cm for men and 80 cm for women in Asian Indians.29 For a 
given BMI, Asian Indians have higher central adiposity. However, the strong association 
between the BMI and diabetes indicated that even minor changes in BMI had adverse 
effects in the population Studies from India shows risk of diabetes in Indians increases at 
a lower BMI than western countries50 Because Indian urban populations have a modest 
increase in overweight and low rates of obesity in association with the rapid emergence 
of diabetes and cardiovascular risk, a body mass index of 21 kg/m2 should be considered 
safe, with a range of 19-23 kg/m2 acceptable; > 23 kg/m2 should be considered 
overweight, and > 25 kg/m2 should be taken to indicate obesity. A waist: hip ratio > 0.88 
in males and > 0.85 in females should be considered to indicate central obesity 57 
Increasing age, obesity, positive family history of diabetes, abnormal sub scapular 
triceps skin fold ratio were all found to be associated with increased risk of DM49Indians 
have an increased susceptibility to type 2 diabetes and insulin resistance compared with 
Europeans Recent studies indicate a rising prevalence of diabetes and insulin resistance. 
Prevalence of diabetes was found to be lower in the low socio-economic group living in 
urban areas compared with the high-income group. 
Clustering of cardiovascular risk factor  
Clustering of cardiovascular risk factors (or syndrome ‘X’) namely central adiposity, 
obesity, hyperinsulinaemia, dyslipidaemia, hypertension and glucose intolerance has been 
 noted in urban Indians in studies by Ramachandran et al. by Mohan et al and by Mishra 
et al. 
Prevention of type 2 diabetes 
Epidemiological data suggest that lifestyle changes involving increased physical 
activity and reduced energy intake will at least partially prevent type 2 diabetes. It is only 
very recently that prospective intervention studies have clearly confirmed the efficacy of 
such measures68,69 The American , and Finnish prevention studies, illustrate the benefits 
in a developed country. Participants in both studies were people who already had IGT 
and were overweight or obese (thus a very high-risk group). With a mean follow-up of 
about 3 years, the two studies had remarkably concordant outcomes, with a 58% 
reduction in incidence of type 2 diabetes, resulting from a reduction in energy intake 
targeted to achieve weight reductions of 7% and 5%, respectively, and an exercise 
regimen targeted to achieve moderate levels of exercise for 150 and 210 minutes per 
week, respectively. 
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5. MATERIALS AND METHODS 
5.1. Study area 
The study was conducted in Kaniyambadi block, North Arcot Ambedker district 
in Tamil Nadu. This Panchayath union is adjacent to the  Vellore town and has a 
population of 102,629 (2000CHAD census). The Community Health Department of 
 Christian Medical College; Vellore has been carrying out an Integrated Community 
health and development programme in this block since 1960. The villages included in this 
study are highlighted in the figure5.1. The villages under study are of same social, 
demographic and cultural characteristics with farming as the main occupation of the 
residents. 
5.2. Baseline survey 
Baseline data for the cohort study came from a cross sectional study on coronary 
heart disease performed by Christian Medical College as a part of Indian Council of 
Medical Research collaborative study on coronary heart disease between 1991and 1993. 
This multicentric study was done by Delhi and Vellore centres in both urban and rural 
areas 
5.3 Baseline survey methodology 
• Twenty three clusters of villages were selected using cluster sampling (probability 
proportionate to size.). 
• All individual between the ages of 30 and 60 were enumerated and invited for the study. 
The response rate was 71%.That is 4693 individuals were studied. 
• Cross sectional data was obtained on several risk factors including socio-demographic, 
biochemical, clinical, anthropometric and lifestyle related risk factors. 
• Among the respondents, biochemical parameters were obtained for 3,108 individuals. 
 
5.4 Baseline biochemical measurement 
Important biochemical measurements done in the baseline survey were- fasting 
plasma glucose, total cholesterol and lipid profile. Fasting plasma glucose was measured 
in the baseline survey after ensuring overnight fasting.. The method used for plasma 
 glucose measurement was glucose oxidase peroxidase (GOD/POD) method.. Oral 
glucose tolerance test was not done in the baseline survey. 
5.5 Measurement of risk factors at the baseline study 
A structured interview schedule was used to obtain information on potential risk 
factors for coronary heart disease and diabetes at the baseline survey like history of 
smoking, alcohol, socioeconomic status. Standard methods were used to measure height, 
weight, and waist and hip circumference. Both systolic and diastolic BP were  measured 
in  the right arm after making  the participant sit comfortably in a chair. 
5.6 Current study 
5.6.1 Study design 
Non concurrent cohort study. 
5.6.2 Study period 
March 2006 – June 2006. 
5.6.3 Study population 
Study population consists of an eligible cohort selected from  the baseline cohort 
after applying certain inclusion and exclusion criteria. 
 
5.6.4 Methodology 
Detailed data of the Participants in the baseline survey were collected. A follow 
up survey was performed retrospectively between March 2006 and June 2006. Of the 
initial cohort, 325 subjects had moved out of the Kaniyambadi block, 310 people were 
dead  and 51 could not be traced. 
Participants at the baseline survey were grouped according to baseline fasting 
plasma glucose. Those who were having fasting plasma glucose value of  80-126mg/dl 
with complete individual clinical biochemical and household data were eligible for the 
 present study. Those who were dead, migrated or not traceable were excluded from the 
study. The population who fitted in the inclusion criteria were considered eligible to 
participate in the present study and formed the   eligible cohort which was 1852. 
5.6.5 Sample size determination 
Table  5.1 
Sample size calculation for each sub group of  fasting plasma glucose 
Baseline FPG 
group 
Cumulative 
incidence(%) 
precision 95%confidence  
interval 
Sample size 
80-89mg/dl 4 2.5 1.5-6.5 246 
90-99mg/dl 11 4.5 6.5  -15.5 193 
100- 
109mg/dl 
25 9 16  -34 93 
110-125 
mg/dl 
50 13 37  -63  59 
 
Due to constraints in time and money, all people in the eligible cohort were not  
included  in the follow up study. Participants in  the eligible cohort were stratified into 
four groups according to baseline fasting glucose (FPG) level as given below. 
         1. FPG value of 80 mg/dl - 89mg/dl. 
2. FPG value of 90mg/dl - 99mg/dl 
3. FPG value of 100-109mg/dl 
4. FPG value of 110-125mg/dl 
The sample size was determined using the formula for each group  
n = 4pq/d2 
 1. For the baseline FPG of 80mg/dl to 89mg/dl 
 Assuming the cumulative incidence for this group is 4% with 95%  confidence 
interval  and precision   of 2.5%        
n1 = 4x4x96/2.52 =246   
95% confidence interval      1.5 - 6.5 
2. For  the baseline FPG of 90mg/dl to 99mg/dl 
Assuming the cumulative incidence for this group is 11% with 95%  confidence interval 
and precision of 4.5 % 
n2 = 4x11x89/4.52  =  193                 95%  confidence interval            6.5  -15.5  
 . 3. For the baseline FPG of 100mg/dl to 109mg/dl 
Assuming the cumulative incidence for this group is 25% with a confidence interval of 
95% and precision of 9% 
  n3 = 4x25x75/92 =93           95% confidence interval         16  - 34  
4.  For baseline FPG of 110mg/dl to 126mg/dl 
Assuming the cumulative incidence for this group is 50% with a confidence interval of 
95% and precision of 13% 
  n4 = 4x50x50/132 =59                 95% confidence interval   37 - 63 
Total sample size required = 246+193+93+59 = 591 
Assuming 90% response rate, the sample size needed was 
80-89mg/dl                             270 
90-99mg/dl                              212 
100-109 mg/dl                          102 
110-125 mg/dl                            65 
To achieve a sample size of 591  assuming 90% response rates  a total of 649 people 
were needed .A sub cohort of 649 people were selected from the eligible cohort by 
 stratified random sampling.  The lowest cut point of FPG for the study group was 80 to 
89 mg/dl and highest cut of FPG was 110-125 mg/dl. 
5.6.6. Data collection 
5.6.7 Blood glucose measurement 
A. Fasting plasma glucose measurement 
All participants in the study cohort were asked to attend a survey site in their 
village between 7 am 8 am after an overnight fasting.  The procedure and purpose of this 
study were explained to the patient and verbal consent was obtained. The  blood sample 
were collected in tubes containing sodium fluoride. To ensure that venous fasting blood 
sugars were reliably determined fasting blood samples were delivered to the laboratory 
within one hour of collection. 
 
B.Oral glucose tolerance test 
Before giving oral glucose, a separate verbal consent was taken from participants 
and the procedure was explained to them ..  75 gram of anhydrous glucose in 250-m1of 
water was given and the blood samples were collected 2 hours later in tubes containing 
sodium fluoride. Samples were delivered to the laboratory within one hour of collection 
Biochemical analysis of blood was performed on fresh samples by glucose oxidase 
method using Hitachi 912 Auto analyzer.  For comparative purpose same biochemical 
test was used for both the baseline study and the follow up study. Both the  baseline and  
the follow up survey plasma glucose was tested in the  CMC biochemistry laboratory. 
5.6.8 Measurement of risk factors at present study  
A large number of risk factors were measured during the baseline survey.   
. A selected number of risk factors were measured in the present survey including weight, 
height, abdominal circumference and  blood pressure, with the same method as described 
 in the baseline study in order to minimize biases. Height and weight were measures using 
standard measuring scales. Waist circumference was measured using ordinary measuring 
tape at the level of umbilicus. Body mass index was calculated using the formula - weight 
divided by the square of the height (kg/m2). 
Variables to assess the socio economic status (SES) of the subject were-Type of 
the house, owner ship of house, land ownership, occupation of the head of the household 
and highest education of the house hold. Physical activity was assessed as perceived by 
the subject about his work related as well as leisure time activity. 
5.6.9. Statistical analysis of the data 
The raw data was entered into Microsoft excel and was verified by the 
investigator..Statistical analysis was carried out using SPSS 12 
 
 
 
 
 
 
 
 
 
 
6. STATISTICAL PROCEDURES 
Outcome definition 
  Since there is considerable controversy regarding diagnostic criteria of Type 2 
diabetes, two different criterias were used for diagnosis of diabetes  
1. Fasting plasma glucose value of 126mg/dl or more 
This criteria WAS put forward by American Diabetes Association in 1997 
2 Either FPG>=126mg/dl or OGTT>=200mg/dl (WHO 1999 criteria) 
 The WHO prefers OGTT over  FPG and  has  specified that if circumstances were not 
allowing for oral glucose tolerance test  to be done then  fasting plasma glucose could be 
used for the diagnosis of diabetes. 
6.1 Incidence of diabetes  
. Calculation of Incidence can be 
A. Cumulative incidence 
B Incidence density 
B. Annual incidence of infection 
Cumulative incidence (CI) reflects the probability that an individual develops a disease 
during a given time period. 
                                                   
         
                                      Number of new cases of a disease during a  
                                 given time   period 
Cumulative incidence          =              ------------------------------------------------ 
 
                                                          Total population at risk 
 Incidence density it is the number of people diagnosed newly as diabetic/total follow up 
years multiplied by 1000. In this cohort study mean year of follow up was 14.16years. 
 Since our study couldn’t collect the data about the exact period in which cases develop 
we assumed that people progressed to diseased state  exactly in the middle of the study 
period. Mean follow up period for the cases was  taken as 7.06 years  and mean follow up 
period for non cases was 14.12 years 
              
                                               New cases of the disease during a period of time                                 
Incidence density =            ----------------------------------------------------- 
   Total person-time of observation 
 
Annual risk of infection It is calculating from cumulative incidence 
CI =1-e-it 
     CI = Cumulative incidence. 
     t = Time period of  the study. 
    i=Annual incidence of infection 
    e = exponential 
i=ln (1-CI)/t     ln is the natural log 
6.2 Calculation of relative risk 
Relative risk and 95% confidence interval are calculated to determine the strength 
of association between selected risk factors and annual incidence of diabetes. Relative 
risk was calculated using the formula. 
 RR= Incidence of disease among exposed / incidence of disease among 
nonexposed 
 95% confidence interval calculated using epi info6. 
6.3 Logistic regression 
   The present study out come was defined as whether progressed to diabetes or not 
.since outcome of the study were measured as dichotomous variable, logistic 
regression was used. 
6.3.1 Univariate analysis  
 Univariate analysis was done to calculate strength of association between 
baseline fasting blood sugar and other selected risk factors of future diabetes. Those 
facters found significant in the univariate analysis were included in the multivariate 
analysis. 
6.3.2 Multivariate analysis 
To assess the independent effect of baseline risk factors associated with diabetes 
multivariate logistic regression was used for analysis..It permits control for confounding 
and evaluation of interaction for a host of variable with great statistical efficiency.  The 
risk factors included for analysis were sex, age, baseline FPG, baseline cholesterol, 
baseline blood pressure BMI and abdominal circumference  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
7. RESULTS 
7.1 Baseline cohort 
 
7.1.1Age sex specific prevalence of diabetes in baseline cohort according to 
FPG>=126 mg/d  l(1997 ADA criteria) 
Table 7.1 showed that the prevalence of type 2 diabetes in baseline cohort as per ADA 
criteria was 2.96%. Prevalence of diabetes increases with age and .highest prevalence 
was for the age group 51-60 years. Males had higher prevalence than females.  
 
 
Table 7.1.1 
 
Age sex specific prevalence of diabetes in baseline cohort according to 
FPG>=126mg/dl 
AGE 
GROUP FREQUENCY FPG>= 126MG/DL 
PREVALENCE PER 100 
 
 Male Female Total Male Female total Male Female Total 
30-40 667 924 1591 15 17 32 2.2 1.8 2.01 
41-50 385 542 927 17 13 30 4.4 23..9 3.23 
51-60 290 299 589 16 14 30 5.5 4.7 5.09 
Total 1342 1765 3107 48 44 92 3.6 2.5 2.96 
  
 
 
7.1.2. Descriptive statistics of the  baseline cohort according to the FPG  
Table 7.1.1 showed that 58.5% of the baseline cohort accepting study criteria 
were females and 41.5% were males. 13.08% of the people belonged to the impaired 
fasting glucose category according to  the American diabetes association’s (ADA) 
revised category.(100-125mg/dl) 
 
Table 7.1.2 
Classification of baseline cohort above 80mg/dl and below 126mg/dl  
BASELINE FPG MALE (%) FEMALE (%) TOTAL (%) 
80-89 551(55.2) 770(54.7) 1321(54.9) 
90-99 309(30.9) 462(32.8) 771(32) 
100-109 98(9.8) 132(9.4) 230(9.6) 
110-125 41(4.1) 44(3.1) 85(3.5) 
Total 999(100) 1408(100) 2407(100) 
 
 
7.2 Descriptive statistics of study cohort 
7.2.1. Age and sex distribution of study cohort 
Table 7.2.1 showed that 47.5% of the study cohort belonged to the 40-50 
age group. Male and female distribution of study cohort was 38.6% and 61.4% 
respectively. Table 7.2.1 showed that male and female population were uniformly 
distributed in each age group. 
Table 7.2.1 
  
 Age and sex distribution of study cohort 
 
AGE GROUP  AT 
PRESENT SURVEY 
(YEARS) 
MALE (%) FEMALE (%) ALL (%) 
40-50 107(46.94) 173(47.79) 280(47.5%) 
51-60 67(29.38) 129(35.64) 196(33.2%)  
61-70 54(23.68) 60(16.57) 114(19.3%) 
Total 228(100) 
 
362(100) 590(100) 
 
 
 
7.2.2Classification of study cohort according to the Baseline glucose 
The total number subjects studied were 590. The planned sample size in FPG of 
group110-125mg/dl could not be achieved .Proportion of participants in each group of 
baseline FPG is comparable with that of baseline cohort. 
 
 
 
Table 7.2.2 Classification of study cohort according to baseline FPG 
BASELINE FPG MALE (%) FEMALE (%) TOTAL (%) 
80-89 109(47.8) 154(42.5) 263(44.4) 
90-99 63(27.6) 121(33.4) 184(31) 
100-109 37(16.3) 62(17.2) 99(16.7) 
110-125 19(8.3) 25(6.9) 44(7.4) 
Total 228(100) 362(100) 590(100) 
 
 
 7.2.3 Baseline characteristics of people in the study cohort according to 
the baseline FPG 
Table 7.2.3 showed  that mean of the baseline systolic and diastolic blood 
pressure at the study cohort  remained  same for all categories of baseline glucose. Mean 
cholesterol, mean age, and mean waist circumferences were increasing along with each 
category of baseline fasting glucose. 
 
 
 
 
 
 
 
 
 
 
 
Table 7.2.3 
 
Baseline characteristics of participants in the study cohort according to baseline 
FPG 
Baseline 
glucose 
(mg/d)l 
 cholesterol Systolic  BP 
Diastolic 
 BP 
Study
age BMI 
Waist 
circumference
Mean 153.1 127.1 80.2 41.41 20.4 70.8 
N 263 263 262 263 260 260 
 
 
 
80-89 
Std. 
Deviation 35 25.6 9.1 8.3 3.1 8.3 
Mean 162.7 126 80.4 43.8 21.5 72. 
N 184 184 182 184 184 182 
 
 
 
90-99 
Std. 
Deviation 35.16 25.3 7.8 8.1 3.8 11.6 
 
 Mean 172.4 128.1 80.7 43.6 
21.9 
 74.5 
 N 99 99 97 99 97 98  
100-109 
Std. 
Deviation 37.3 19.6 6.7 7.9 3.8 10.9 
Mean 175.3 128.9 80.9 45.5 22.9 75.6 
N 44 44 44 44 43 44 
Std. 39.6 24.5 10.3 8.123 3.90926 16.338 
 
 
 
110-125 
Total  590 589 585 590 584 584 
 
7.3 Incidence of type2 diabetes in study cohort 
As described earlier three different methods were used for calculation of Incidence 
A. Cumulative incidence 
B Incidence density 
B. Annual incidence of infection 
Cumulative incidence (CI) reflects the probability that an individual develops a disease 
during a  given time period. 
                                                          Number of new cases of a disease during a  
                                 given time   period 
Cumulative incidence          =              ------------------------------------------------ 
                                                          Total population at risk 
              
                                               New cases of the disease during a period of time                                 
Incidence density =            ----------------------------------------------------- 
   Total person-time of observation 
 
 Mean follow up years  for the study were  14.16  Mean follow up years for cases were 
considered as 7.08 years  assuming  that the participants progressed to cases  exactly at 
the middle of the follow up years. 
Annual incidence was calculated by the formula 
i=   ln  (1-CI)/t    where  i is the annual incidence, t time period of the study and CI is the 
cumulative incidence. 
Annual incidence and incidence density measures the incidence rate where as the 
cumulative incidence measures the risk. of developing  the disease. 
Present study diagnosed diabetes based on two different diagnostic criteria  
1. Fasting blood sugar >=126mg/dl alone.  ( ADA 1997) 
2. Either FPG >=126mg/dl or OGTT>=200mg/dl. (WHO-1999) 
 Table 7.3.1A showed that Incidence of diabetes of study cohort was 12.86 per 1000 PY 
using the criteria of FPG alone and 18.65 per1000 PY when defined by either FPG 
>=126mg/dl or OGTT>=200mg/dl.  Incidence density  of diabetes  using FPG alone as 
criteria was 13.65 per person years  and  either FPG or OGTT  was 19.63 per1000 person 
years .  
 Both approaches should yield similar results.The minor differences of the results 
in  the annual incidence of the diabetes  and incidence density weredue to the differences 
in the computational methods used..The annual incidence rate calculated from the 
cumulative incidence assumes a constant rate of incidence through out the time period 
resulting in the survivors demonstrating a negative exponential curve.in general estimate 
arrived in this method will be slightly smaller than the incidence rate obtained through 
using person years as the denominator.   
 As shown in the table7.3.1 diabetes defined by the either fasting plasma glucose 
(FPG) or oral glucose tolerance (OGTT)prodces a higher estimate for incidence of 
the diabetes. 
Table 7.3.1A 
Incidence of diabetes in study cohort according to Two different criteria 
DIAGNOSTIC 
CRITERIA 
NUMBE
R OF 
PEOPLE 
NUMBE
R OF 
CASES 
CUMULATIV
E  
INCIDENCE 
FOLLOW- 
UP 
(PERSON- 
YEARS) 
INCIDENC
E  
DENSITY 
PER1000PY 
ANNUAL 
INCIDENCE 
PER 1000PY 
FPG>=126mg/dl  
590 
 
104 
 
17.6% 
 
 
7620.86 
 
13.65 
 
12.86 
FPG>=126mg/dl 
or 
OGTT>=200mg/d
l 
 
590 
 
144 
 
24.4% 
 
7336.32 
 
 
19.63 
 
 
18.65 
 
 
 
7.4 Association between risk factors and incidence of type2 diabetes 
7.4.1 Age and incidence of diabetes 
 Table 7.4.1Aand 7.4.1B showed that annual incidence of diabetes increased with 
age. Relative risk was calculated from the cumulative incidence considering 30-40 age 
group as  the reference category. 
 
 
 
Table 7.4.1A Association between age and type2 diabetes (FPG>=126mg/dl) 
 AGE 
GROUP 
AT BASE 
LINE 
SURVEY 
FREQUENCY 
PROGRESSION 
TO 
FPG>=126MG/DL 
CUMULATIVE 
INCIDENCE 
 
ANNUAL 
INCIDEN
CE 
PER1000 
RR(CI) 
30-40 280 38 13.6 9.72 1 
41-50 196 36 18.4 13.38 1.32 
51-60 114 30 26.3 20.15 1.93 
 
Table7.4.1B Association between age and type2 diabetes (either FPG>=126mg/dlor 
OGTT>=200mg/dl) 
AGE 
GROUP FREQUENCY 
PROGRESSION 
TO FPG>= 126 
OR OGTT>=200 
CUMULATIVE 
INCIDENCE 
 
ANNUAL 
INCIDENCE 
PER 1000PY 
RR(95% 
CI) 
30-40 280 52 18.6 13.7 1 
41-50 196 50 25.5 19.64 1.37 
51-60 .114 42 36.8 30.64 1.97 
 
 
 
7.4.2 Baseline Fasting plasma glucose and annual incidence of type2 diabetes 
Table7.4.2A and table7.4.2B, showed   that as baseline glucose increased risk of 
future diabetes also increased.  This result is in agreement with western longitudinal 
studies especially Pima Indian studies and Hoorn study in Dutch population.   
 
Table 7.4.2A 
Annual incidence when diabetes defined by FPG alone 
Base 
line 
FPG 
frequency Progression to FPG>=126mg/dl 
Cumulative 
Incidence (%) 
Annual 
incidence per 
1000 
RR(ci) 
 80-89 263 24 9.1 6.38 1 
90-99 184 29 15.8 11.43 1.74 
100-109 99 29 29.3 23.11 3.22 
110-125 44 22 50 46.21 7.24 
 
 
 
Table7.4.2 B 
Annual incidence when diabetes defined by FPG>=126 or OGTT>=200mg/dl 
Base 
line 
FPG 
Frequency 
 
Progression 
to FPG>= 
126 or 
OGTT>=200 
Cumulative 
Incidence (%) 
Annual 
incidence per 
1000PY 
CI 
80-89 263 39 14.8 10.7 1 
90-99 184 43 23.4 17.74 1.58 
100-109 99 38 38.4 32.28 2.59 
110-125 44 24 54.5 52.56 4.91 
 
7.4.3 Log of annual incidence and diabetes as defined by either FPG criteria 
Fig 7.4.3 showed that when log of annual incidence plotted against baseline glucose the 
graph described a linear relation 
 
 Fig 7.4.3 Log of annual incidence and diabetes as defined by either FPG criteria 
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7.4.4Linear regression  for log of annual incidence 
 
Using the  regression equation 
 
y =  a + bx                                        
where    a  is  the   constant 
b-regression coefficient 
y-dependant or outcome variable  (log  of annual incidence) 
 x - Is the independent or predictor  variable 
    y=1.85 
  a= 1.168 
  b=0.655 
 
 
 
 7.4.5 Projected annual incidence of baseline FPG below 80mg/dl  
 
Assuming the FPG group 60- 69mg/dl and70-79mg/dl follows the linear relation 
log annual incidence is calculated for these groups 
Log annual incidence of  FPG of 70-79mg/dl group       1.85 -0.655  =  1.195 
Log annual incidence of  FPG of 70-79mg/dl group        1.195-0.655  =  0.54 
 
Antilog of this values  will give  the  annual incidence of that group  
   
 Projected annual incidence of 60-69mg/dl group               1.71per 1000PY 
Projected annual incidence of 70-79mg/dl group                3.303 per 1000PY 
7.4.6Incidence of type2  diabetes in baseline cohort 
Incidence of diabetes in the study cohort cannot be applied to baseline cohort since study 
cohort is lacking the population representative of the baseline glucose value less than 
80mg/dl.Since log of annual incidence plotted against baseline FPG  followed  linear 
relation .Annual incidence of FPG 60-69 group and 70-79 were calculated from 
extrapolated results. 
  It would  be interesting to apply baseline FPG specific incidence rate to the entire  
baseline cohort  to estimate the expected 15 year  cumulative incidence in the group. 
 
Table7.4.6  projected Incidence of type2 diabetes in baseline cohort as     defined by 
FPG>=126mg/dl or  OGTT >=200mg/dl 
BASELINE FPG TOTAL  ANNUAL INCIDENCE PER1000 
EXPECTED  
INCIDENCE 
60-69 91 1.71  
0.16 
  
Pr
oje
cte
d  
an
nual incidence in the baseline cohort 
 28.35/3016*1000       =   9.4 per 1000 PY 
 
 
 
Cumulative incidence =    1-e-it          i =    0.0094 
                                                                t =   14.16 
                                                                it  =   0.0094 x 14.16  = 0.1331 
                                                               -it  =  - 0.1331 
                                                e –it   = 0.875 
Cumulative incidence   =   1 -  0.875 =    =12.5% 
                                                                     
Assuming baseline cohort also followed the annual incidence of study cohort  
 The cumulative incidence of baseline cohort                12.5% 
 
Comparison of  the projected cumulative incidence of baseline cohort  to the baseline 
prevalence in 1991 survey (2.9%)  showed  that there has been    currently atleast  4.3  
70-79 518 3.303 1.71 
 
80-89 1321 
 
6.38 8.43 
 
90-99 771 11.43 8.81 
 
100-109 230 23.11 5.31 
 
110-125 85 46.21 3.93 
 
Total 3016 - 28.35 
 fold increase in burden  of diabetes  if the baseline cohort followed the same  incidence 
rate. 
 
7.4.7. Cumulative incidence of type2 diabetes according to baseline fasting 
plasmaglucose 
The present study participants are classified according to baseline fasting plasma 
glucose and measured risk of diabetes across each category. Below an FPG of 85 mg/dl 
less than 7% participants progressed to diabetes.  Incidence of diabetes started to rise in 
those with FPG 95mg/dl and above.  Incidence of diabetes was highest in the group with 
FPG 110-125mg/dl. 52.54% of the study participants in the group with FPG 110-
125mg/dl became progressed to diabetes when using FPG or OGTT as diagnostic criteria. 
 
 
 
 
 
 
 
Fig7.4.7A.Diabetes defined by FPG>=126 mg/dl 
 Fifteen years diabetes incidence according to thebaseline fasting 
plasma glucose
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Table 7.4.7B Diabetes defined by either FPG or GTT>=200mg/dl 
Fifteen years diabetes incidence according to thebaseline  fasting 
plasma glucose
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7.4.8 Association between sex and type2 diabetes 
 Annual incidence of diabetes as defined by two criteria (table7.4.4A& 7.4.4.) in 
males and females were calculated separately and relative risk was estimated.it showed 
that males were having higher risk of diabetes than females..Global estimate of diabetes 
also showed that India male sex is more at risk than female for type 2 diabetes 
Table 7.4..8A. 
Annual incidence of diabetes as defined by FPG alone 
 
SEX 
Frequency 
 
FPG>=126M
G/DL 
Cumulative 
Incidence (%) 
ANNUAL 
INCIDENCE 
PER1000 
RR(95%CI) 
Female 362 49 
 
13.53 9.70 1 
Male 228 55    24.12 
18.40 
 1.78(1.15-2.77)
 
Table 7.4.8.B 
Annual incidence of diabetes as defined by either FPG or OGTT 
 
SEX 
Frequency 
 
 
BY  FPG>=126 
OGTT>=200 
Cumulative 
Incidence (%) 
ANNUAL 
INCIDENCE 
PER 1000 
RR(95%CI) 
female 362 79  21.81 16.41 1 
Male 228 65  28.50 22.37 
1.31(0.81-
1.92) 
7.4.9 Baseline blood pressure and incidence of diabetes 
As shown in 7.4.9A to 7.4.9 B tables those with hypertention had nearly two 
times higher risk of developing future diabetes compared to the reference category. This 
difference was statistically significant 
Table 7.4.9.A Incidence of diabetes as defined by FPG alone 
BLOOD 
PRESSURE 
Frequency 
 FPG>=126MG/DL 
Cumulative 
Incidence (%) 
ANNUAL 
INCIDENCE 
PER 1000 
RR(95%CI) 
SBP<140 
or DBP<90 461 
67 
 14.53 10.54 
1 
 
 SBP>=140 
or  
DBP>=90 
 
132 
 
37 
 28.03 21.93 
1.93(1.21-
3.08) 
 
Table 7.4.9B 
Incidence of diabetes as defined by either FPG or OGTT 
BLOOD 
PRESSURE 
Frequency 
 
FPG>=126 OR 
OGTT>=200 
Cumulative 
Incidence (%) 
ANNUAL 
INCIDENCE 
PER 1000 
RR(95%CI)
SBP<140 
or DBP<90 
461 
93 20.17 15.13 1  
SBP>=140 
or  DBP>=90 132 51 38.63 32.56 
1.92(1.27-
2.89) 
 
7.4.10. Annual incidence of diabetes according to baseline cholesterol 
7.4.6A to 7.4.6D showed that baseline cholesterol above 150mg/dl annual 
incidenc seems to be increased. A cholesterol value of >=200mg/dl had 3-4 times higher 
risk of getting diabetes compared to cholesterol value <=150mg/dl 
Table 7.4.10.A 
 Annual incidence of diabetes as defined by FPG alone 
TQTAL 
CHOLESTROL 
Frequency
 FPG>=126MG/DL ) 
ANNUAL 
INCIDENCE 
PER1000 
RR(95%CI)
<=150 
 
243 
 27          11.11 7.85 1 
 
151-200 
 
258 
 50 19.37 14.36 
1.74(1.03-
2.96) 
>=201 89 27 30.33 24.10 2.73(1.46-5.11) 
 
Table7.4.10.B Annual incidence of diabetes according to baseline cholesterol as 
defined by either FPG or OGTT 
  
TQTAL 
CHOLESTROL 
Frequency 
 
 
FPG>=126MG/D
L  
OGTT>=20OMG/
Cumulative
Incidence 
(%) 
ANNUAL 
INCIDENCE 
PER 1000 
RR(95%CI) 
 
<=150 
 
    243 
 
38 
 
15.63 
 
11.33 
 
1 
 
151-200 
258 
 
 
68 
 
26.35 
 
20.4 1.68(1.07-2.66)
 
>=201 
 
89 
 
38 
 
       42.69 
 
37.12 2.73(1.59-4.70)
 
 
7.4.11 Physical activity at baseline survey and Annual incidence of diabetes 
Table7.4.7A & 7.4.7B showed that heavy physical activity had a protective effect on 
type2 diabetes. People who were heavy workers had low incidence of diabetes. 
 
Table7.4.11A Diabetes defined by FPG alone 
 
PHYSICAL 
ACTIVITY 
Frequency 
 
 
PROGRESSION 
TO FPG>=126 
Cumulative 
Incidence (%) 
ANNUAL 
INCIDENCE 
PER 1000 
RR(95%CI)
Mild to 
moderate 336 70 20.83 15.57 1 
Heavy 254 34 13.39 9.58 0.642(40-1.02) 
 
Table 7.4.11.B Annual incidence of diabetes as defined by either FPG or OGTT 
 
PHYSICAL 
ACTIVITY 
Frequency 
 
 
PROGRESSION 
TO 
FPG>=126OR 
OGTT>=200 
Cumulative 
Incidence (%) 
ANNUAL 
INCIDENCE 
PER 1000 
RR(95%CI) 
Mild to 
moderate 336 
95 
 28.27 22.15 1 
Heavy 256 49  19.14 14.29 0.677(0.45_1.01)
 
7.4.12 Body mass index at baseline survey and annual incidence of diabetes  
Table 7.4.8A to shows that as compared to the reference category (<=20kg/m2 the 
group with BMI 21kg/m2-24kg/m2 had two fold risk of getting diabetes.  This risk 
 increases to 5 times when BMI increases>=25kg/m2.This showed that risk of future 
diabetes started at a  lower BMI  compared to the western countries. 
Table 7.4.12.A 
Diabetes defined by FPG alone 
 
BMI 
Frequency
 
 
PROGRESSION 
TO FPG>=126 
Cumulative 
Incidence (%) 
ANNUAL 
INCIDENCE 
PER 1000 
RR(95%CI)
<=20kg/m2 306 26 8.49  5.92 1 
21-24 kg/m2 194  43 
22.16 
 16.72 
2.61(1.51-
4.53) 
>=25 kg/m2  80 32 
40 
 34.06 
4.71(2.56-
8.69) 
 
Table 7.4.12.B 
 Diabetes as defined by either FPG or OGTT 
BMI Frequency  
PROGRESSION 
TO EITHER 
FPG>=126OR 
OGTT>=200 
Cumulative 
Incidence (%) 
ANNUAL 
INCIDENCE 
PER 1000 
RR(95%CI)
<=20 
kg/m2 306 
41 
13.39 
9.59 1 
21-24 
kg/m2 194 
61 
31.44 
25.16 2.34(1.49-3.71) 
>=25 
kg/m2 80 
38 
47.5 
42.96 3.54(2.07-6.06) 
 
7.4.13 Socio economic status annual incidence 
Table7.4.9 shows that people from higher socioeconomic status are at higher risk 
of getting diabetes than lower socioeconomic status. 
 
 
 
 
  
 
Table 7.4.14A 
Diabetes defined by FPG alone 
SES Frequency  
PROGRESSION 
TO 
FPG>=126ALONE
Cumulative 
Incidence (%) 
ANNUAL 
INCIDENCE 
PER 1000 
RR(95%CI)
Low 91 11 12.08 8.59 1 
Middle 421 70 16.6 12.12 1.37(0.67-2.87) 
High 78  23 29.4 23.29 
2.43(1.05-
5.73) 
 
Table 7.4.14.B 
Diabetes as defined by either FPG or OGTT 
SES Frequency  
PROGRESSION 
TO EITHER 
FPG>=126OR 
OGTT>=200 
Cumulative 
Incidence (%) 
ANNUAL 
INCIDENCE RR(95%CI)
Low 
91 
14 15.38 11.13 1 
Middle 
421 
104 24.70 18.91 1.6(0.85-3.08) 
High 
78 
26 33.33 27.03 2.16(1.00-4.72) 
 
 
7.4.15 Annual incidence of diabetics according to baseline waist circumference 
For definition of abdominal obesity cut off used was males >=85cm of waist 
circumferences and females>=80cm.  These measurements were done at the level of 
umbilicus using ordinary measuring tape. 
Table 7.4.15.A  
 Diabetes defined by FPG alone 
WAIST 
CIRCUMFERENCE 
Frequency
 
PROGRESSION 
TO FPG>=126 
ALONE 
Cumulative
Incidence 
(%) 
ANNUAL 
INCIDENCE RR(95%CI)
Non obese 492 66 13.41 10.10 1 
Obese 98 38 38.77  2.89(1.79-4.66) 
 
Table 7.4.15.B 
 Diabetes as defined by either FPG or OGTT 
WAIST 
CIRCUMFERENCE 
Frequency
 
PROGRESSION 
TO EITHER 
FPG>=126OR 
OGTT>=200 
Cumulative
Incidence 
(%) 
ANNUAL 
INCIDENCE 
PER 1000 
RR(95%CI)
Non obese 492 94 19.10 15.23 1 
Obese 98 50 51.02 49.08 2.67(1.74-4.09) 
 
7.5 Association between selected risk factors at present survey and type 
2 diabetes 
7.5.1 Association between obesity at present survey and type 2 diabetes  
Table 7.5.1A&B showed that people who progressed to obesity during 15 years time 
period have higher risk of diabetes than nonobese people. 
Table 7.5.1A 
Diabetes defined by >=126mg/dl 
WAIST 
CIRCUMFERENCE 
Frequency
 
PROGRESSION 
TO FPG>=126 
ALONE 
Cumulative
Incidence 
(%) 
ANNUAL 
INCIDENCE 
PER 1000 
RR(95%CI)
Non obese 354 42 11.86 8.41 1 
Obese 138 24 17.39 12.73 1.46(0.83-2.59) 
 
 Table7.5.1B  
Diabetes as defined by either FPG>=126mg/dlor OGTT>=200mg/dl 
WAIST 
CIRCUMFERENCE 
Frequency
 
PROGRESSION 
TO EITHER 
FPG>=126OR 
OGTT>=200 
Cumulative
Incidence 
(%) 
ANNUAL 
INCIDENCE 
PER 1000 
RR(95%CI)
Non obese 354 61 17.23 15.56 1 
Obese 138 33 23.9 18.21 1.38(0.85-2.27) 
 
7.5.2 Association between BMI  at present survey and type 2 diabetes 
The results showed that people who were converted to BMI>=20 were having higher 
risk of diabetes than reference category(<=20kg/dl) 
Table 7.5.2A 
Diabetes defined by FPG alone 
 
BMI 
Frequency 
 
 
PROGRESSION 
TO FPG>=126 
Cumulative 
Incidence 
(%) 
ANNUAL 
INCIDENCE 
PER 1000 
RR(95%CI)
<=20kg/m2 144 12        8.33      5.8 1 
21-24 kg/m2 226  37 
16.37 
 12.03 
1.96(0.95-
4.13) 
>=25 kg/m2 120  17 14.16 11.38 
1.69(0.74-
3.96) 
 
Table 7.5.2.B 
Diabetes as defined by either FPG or OGTT 
BMI Frequency  
PROGRESSION 
TO EITHER 
FPG>=126OR 
OGTT>=200 
Cumulative 
Incidence (%) 
ANNUAL 
INCIDENCE 
PER 1000 
RR(95%CI)
<=20 
kg/m2 144 
19 
9.95 
9.43 1 
 21-24 
kg/m2 226 
55 
19.15 
18.21 1.92(1.02-3.37) 
>=25 
kg/m2 
 
120 27 17.71 
16.83 1.78(0.87-3.38) 
 
7.5.3 Association between blood pressure at present survey and type 2 
diabetes 
Diabetes defined by FPG alone showed that incidence of diabetes and incidence 
of blood pressure are not associated. 
Table7.5.3A 
 Present blood pressure and Diabetes as defined by either FPG or OGTT 
BLOOD 
PRESSURE 
Frequency 
 FPG>=126MG/DL 
Cumulative 
Incidence (%) 
ANNUAL 
INCIDENCE 
PER 1000 
RR 95%CI) 
SBP<140 
or DBP<90 381 
56 
 14.7 10.59 
1 
 
SBP>=140 
or  
DBP>=90 
77 11  14.29 10.27 
0.97(0.46-
2.02) 
 
 
 
Table 7.5.3B 
Present blood pressure and diabetes defined by either FPG or OGTT 
BLOOD 
PRESSURE 
Frequency 
 
FPG>=126 OR 
OGTT>=200 
Cumulative 
Incidence (%) 
ANNUAL 
INCIDENCE 
PER 1000 
RR(95%CI)
SBP<140 
or DBP<90 4893 72 18.9      13.96 
1 
 
SBP>=140 
or  DBP>=90 943 21 27.27 21.23 
1.44(0.81-
2.57) 
7.6 Univariate analysis of selected variables 
 Univariate analysis of selected risk factors with risk of diabetes was done by using both 
criteria.It was  seen from this analysis that basline glucose above 90mg/dl,sex, age above 
50 years, baseline BP>=140/90mmof Hg ,cholesterol mg/dl, physical activity  
at baseline ,BMI>=21kg/m2 and  waist circumference of 85 or above for males and 80 
or above for females were  associated with risk of future diabetes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 tTable 7.6.1B 
Univariateanalysis Diabetes defined by FPG>= 126 mg/dl or OGTT>=200mg/dl    
  
RISK FACTOR ODDS RATIO CONFIDENCE INTERVAL P VALUE 
Baseline  FPG 
80-89 
90-99 
100-109 
110-125 
 
1 
1.811 
4.045 
9.680 
- 
1.023-3.208 
2.213-7.396 
4.711-19.891 
- 
0.042* 
0.000* 
*0.000* 
Sex 
Female 
male 
 
1 
1.527 
 
 
- 
0.997--2.341 
 
 
- 
        0.052 
.  
Age 
30-40 
41-50 
51-60 
 
1 
1.363 
2..158 
 
- 
0.823-2.256 
1.269-3.668 
 
- 
0.191 
0.000* 
Cholesterol 
<=150 
151-200 
>=200 
               1 
1.923 
3.484 
             - 
1.160-3.188 
1.905-6.371 
         - 
 
0.011* 
         0.000* 
 
Blood pressure 
SBP<140/DBP<90 
SBP>=140/DBP>=90 
 
1 
2.273 
 
- 
1.435-3.60 
 
 
- 
0.000* 
 
Physical activity 
Mild to moderate 
Heavy 
 
 
1 
0.631 
 
- 
0.355-1.121 
 
 
0.116 
BMI 
<=20 
21-24 
>=25 
1 
2.084 
5.979 
- 
1.236-3.512 
3.276-10.912 
 - 
0.006* 
.000* 
SES 
                              Low 
High  
1 
2.43 
- 
1.05-5.73             0.04* 
Abdominal obesity 
Non Obese 
Obese 
1 
4.088 
- 
2.524-6.620 .004* 
Abdominal obesity  
Non obese 
obese 
1 
1.564 
      - 
( 0.906-2.698) 
 
0.108 
 
  
RISK FACTOR 
 
ODDS RATIO 
 
CONFIDENCE 
INTERVAL
 
P VALUE 
BaselineFPG 
80-89 
90-99 
100-109 
110-125 
 
1 
1.730 
3.619 
6.807 
 
- 
1.071-2.793 
2.126-6.160 
3.442-13.463 
 
 
.025*    
.000* 
.000* 
 
Sex 
Female 
male 
 
1 
1.429 
 
- 
.976-2.090 
 
- 
0.06 
Age 
30-40 
41-50 
51-60 
 
1 
1.348 
2.489 
 
 
 
- 
 .862-2.11 
1.549-4 
 
 
 
.191 
.000* 
 
 
Cholesterol 
<=150 
151-200 
>=200 
 
1 
1.930 
4.019
 
- 
2.332-6.925 
1.239-3.007
 
- 
.000* 
.004*
Blood pressure 
SBP<140/DBP<90 
SBP>=140/DBP>=90 
 
1 
2.471 
 
- 
1.627-3.753 
 
 
- 
0.000* 
Physical activity 
Mild to moderate 
Heavy 
1 
0.645 
- 
.0.388-1.070 
 
 
- 
.089 
BMI 
<=20 
21-24 
>=25 
1 
2.282 
5.552 
2.529 
- 
1.456-3.576 
3.189-9.667 
- 
0.000* 
0.000* 
    
Abdominal obesity 
Non Obese 
Obese
1 
4.410 
1 959
- 
2.797-6.954 
- 
0.000* 
Abdominal obesity in 
present survey 
Non Obese 
Obese 
 
1 
1.509 
 
- 
.935-2.436 
 
- 
.092 
 
 
7.6.2 Multivariate analysis 
The present study measures the outcome as dichotomous variable, like diabetes 
present or absent .So independent risk analysis logistic regression was used. 
 Multi variate logistic regression 
 The risk factors that had shown significance in univariate analysis were included 
in multivariate analysis. After adjusting with other selected risk factors baseline fasting 
plasma glucose group of 110-125mg/dl was the powerful  predictor of future diabetes. In 
both criteria. It also had shown that risk of FPG in predicting future diabetes started  with 
the FPG of 110-125mg/dl .  Other predictors when diabetes defined by either FPG or 
OGTT were sex ,baseline blood pressure>=140/90mm of Hg, baseline cholesterol above 
200mg/dl, BMI>=21kg/m2, waist circumference of 85 and above for males and 80 and 
above for females. But when used FPG alone only sex  and BMI >=25kg/m2 were shown 
significant. 
 
 
 
 
 
 
 
 
 
Table7.6.2.A 
 Multivariate logistic regression diabetes defined by FPG>=126 mg/dl 
 
RISK FACTOR 
 
ODDS RATIO 
 
CONFIDENCE 
INTERVAL 
 
P VALUE 
Baseline 
80-89 
90-99 
100-109 
110 125
1.573 
3.091 
6.336 
0.865-2.861 
1.605-5.953 
2.875-13.963 
0.138 
0.001* 
0.000* 
Sex 
Female 
male 
 
1 
1.725 
 
- 
1.053-2.827 
 
- 
0.030* 
 Age 
30-40 
41-50 
51-60 
1 
1.145 
1.460 
 
- 
0.650-2.018 
0.795-2.683 
 
- 
0.639 
0.223 
 
Cholesterol 
<=150 
151-200 
>=200 
 
1 
1.369 
1.620 
 
1 
0.776-2.413 
0.807-3.252 
 
- 
0.278 
0.175 
Blood pressure 
SBP<140/DBP<90 
SBP>=140/DBP>=90 
1 
1.412 
 
- 
0.805-2.478 
 
- 
0.229 
Physical activity 
Mild to moderate 
Heavy 
 
1 
0.646 
 
- 
0.338-1.235 
 
     - 
0.186 
BMI 
<=20 
21-24 
>=25 
1 
1.754 
3.331 
- 
0.970-0.3.173 
1.482-7.484 
- 
0.063 
0.004* 
SES 
Low 
High  
1 
1.2 
- 
.770-2.4 .315 
 
Abdominal obesity 
Non Obese 
Obese 
 
 
1 
1.510 
 
 
- 
.733-3.109 
 
 
- 
0.264 
Abdominal obesity in present survey 
Non Obese 
Obese 
 
 
1 
1.119 
 
- 
0.607-2.064 
 
- 
0.719 
*  statistically significant 
 
 
 
Table 7.6.2B 
.Diabetes defined by either FPG>=126 mg/dl or OGTT>=200mg/dl 
RISK FACTOR ODDS RATIO CONFIDENCE INTERVAL P VALUE 
BaselineFPG 
80-89 
90-99 
100-109 
110-125 
 
1 
1.467 
2.734 
4.096 
 
 
- 
.881-2.442 
1.518-4.924 
1.917-8.753` 
 
- 
0.141 
0.001* 
0.000* 
 Sex 
Female 
male 
 
1 
1.576 
 
- 
1.015-2.447 
 
- 
0.043* 
Age 
30-40 
41-50 
51-60 
 
1 
1.077 
1.682 
 
- 
0.650-1.784 
0.981-2.885 
 
- 
0.774 
0.059 
Cholesterol 
<=150 
151-200 
>=200 
 
1 
1.382 
2.045 
 
- 
0.841-2.269 
1.099-3.805 
 
- 
0.202 
0.024* 
Blood pressure 
SBP<140/DBP<90 
SBP>=140/DBP>=90 
 
1 
1.628 
 
- 
.0.982-2.698 
 
 
- 
0.059 
Physical activity 
Mild to moderate 
Heavy 
 
1 
0.661 
 
- 
.0.371-1.177 
 
- 
0.160 
SES 
Low 
High  
 
1 
1.1
 
- 
0.654-1.43
 
- 
.646
 
BMI 
<=20 
21-24 
>=25 
 
1 
1.877 
2.529 
 
- 
1.124-3.133 
1.201-5.326 
 
- 
0.016* 
0.015* 
Abdominal obesity 
Non Obese 
Obese 
 
1 
1.959 
 
- 
1.013-3.788 
 
- 
0.046* 
Abdominal obesity in 
present survey 
Non Obese 
Obese 
 
 
 
1 
1.060 
 
 
 
- 
0.617-1.821 
 
 
- 
0.832 
 
*  statistically significant 
 
8.Discussion 
 
The rural population in Kaniyambadi block was studied for the prevalence of 
coronary heart disease and its risk factors by ICMR-CMC group in 1991-1993.  The 
present study made use of this situation and considered the 1991 study as the 
baseline survey for the follow-up study. Main objective of the study is to determine 
predictive validity of fasting blood  glucose in risk of  developing future diabetes 
This study selected a sub cohort from the baseline survey after applying certain 
inclusion and exclusion criteria .The sample size required was 591. Assuming 90% 
 response rate 649 people were invited for the  follow up study.  The overall response 
rate was 91%. Even though response rate was high it was not uniformly distributed 
among the sub groups. The Required sample size for the FPG of 90-99mg/dl group 
and FPG of 110-125mg/dl  wasn’t  adequate.  
The study population consisted of 228 men and 362 women with a mean age 
of  41.99(SD 8..27)  years at the baseline, who were followed up after   14.16 years 
(SD 0.83).. To determine predictive validity of fasting blood  glucose baseline FPG 
were classified into different groups .The lowest group was 80-89mg/dl and highest 
group was 110-125mg/dl.  Other selected risk factors at baseline survey  like age 
,sex, cholesterol blood pressure BMI, and abdominal circumference on the risk of 
type2 diabetes  were also studied. Risk factors measured at present survey were 
blood pressure, BMI, waist circumference etc. 
Incidence of diabetes 
 The cumulative incidence of diabetes was 17.6 % according to the ADA 
criteria.  and 24.4%   according to the WHO-1999 criteria: The annual incidence 
was 11.16 per1000PY when calculated by fasting plasma glucose criteria by ADA 
and 18.65per 1000 PY when calculated by either fasting or 2hr OGTT. .It appears 
that WHO criteria increases the overall sensitivity of the study but with the  present 
data one may not be able to say that specificity  has decreased. As a general rule this 
increase in sensitivity can decrease the specificity.  It can be seen that the values of 
annual incidence and incidence density were almost equal. The slight difference is 
because in the  annual incidence, occurrence of new cases were at a constant rate 
,whereas in the incidence density the study assumed that new cases had occurred at 
the half period of  the follow up time . 
              Predictive validity of fasting plasma glucose in detecting future 
diabetes. 
 The baseline fasting plasma glucose of study population varied from 80 to 
125 mg/dl. Of the 447 participants with normal fasting glucose (80-99mg/dl) at the 
baseline,53 participants(11.9%)  developed  diabetes(ADA criteria) at  a mean 
follow-up period of 14.16 years . Of the 143 participants with impaired fasting 
glucose at the baseline (110-125mg/dl), 51 participants (35.7%) had diabetes at 
follow-up (ADA criteria) According to the WHO criteria, the cumulative incidence 
 was 18.5% for participants with normal fasting glucose  and 43.3.% for those with  
impaired fasting glucose.   
 To measure the distribution of risk  of future diabetes in baseline glucose the 
present study categorized the baseline glucose into different groups and measured 
strength of association between baseline glucose and  type2 diabetes by both 
univariate analysis and multivariate analysis Univariate analysis showed that when 
the  base line glucose  level increased. the risk  of future type2 diabetes  also 
increased.  Incidence of diabetes started to rise in those with FPG 90-99mg/dl group 
and was highest in the group with baseline glucose of 110-125mg/dl.Attempt was 
made to arrive at level of blood sugar above which the risk of diabetes is notifiably 
higher.Eventhough there is an incremental risk of developing diabetes with any 
increase in FPG level, above 95mg/dl this risk appears to increase higher.. The same 
trend was seen in the ADA and WHO diabetes criteria. Multiple logistic regression 
showed that risk started with 100-110mg/dl category of FPG and FPG group with 
110-125mg/dl had 4-5 times higher risk of developing future diabetes than reference 
category (80mg/dl-89mg/dl). The results of this study showed that fasting glucose 
category of 100-125 mg/dl is an independent predictor of future diabetes for a follow 
up period of 14.16 years. 
 There are a number of longitudinal studies done by western countries with 
similar results 38 ,but there is no longitudinal study done  in  India  to measure 
whether impaired fasting glucose is a real risk factor or not..Hoorn study63 showed 
that of those with normal fasting at baseline, 4.5% had diabetes at the follow-up 
examination and 64.5% of the participants who had both impaired fasting  at 
baseline progressed to diabetes.. Even in western countries, very few studies are 
done about predictive validity of fasting blood sugar and future diabetes Most of the 
studies were based on impaired glucose tolerance and risk of future diabetes. 
 This result strongly supports the revised criteria of lowering the cut off for 
impaired fasting glucose from 110 to 100mg/dl by ADA. In fact the result of the 
present study suggests that lowest cut point of the impaired fasting glucose that 
predict future diabetes can be  lowered from 100 to 95mg/dl. 
To estimate the incidence of the whole baseline cohort the present result was 
not sufficient since the study population was lacking FPG below 80mg/dl.Since log 
annual incidence according to the baseline FPG followed the linear relation , FPG of 
 60-69mg/dl group and 70-79mg/dl group can be calculated by extrapolating the 
present result. The projected annual incidence and cumulative incidence for the 
disease free baseline cohort was calculated. The projected cumulative incidence was 
12.5% and annual incidence was 9.4 per 1000 PY. 
                                   Thus it appears that if one were to start with nondiabetic( 
based on the ADA criteria )population of 3016 individual  with a mean fasting blood 
glucose of 87.21(sd 10.1) and mean age of  41.2(sd 8.7) 12.5% would have  
progressed to the diabetes stage (ADA criteria) during a  period of 14.16 years . This 
indeed would be underestimating the true prevalence   as it excludes those who were 
diabetic in the baseline survey and survive for the duration of the study.  
 The prevalence of diabetes in  the baseline study based on the ADA criteria 
(reclassified during the present survey) showed  2.9%.and current burden of the 
disease estimated to be  at least four times high. Thus there is adequate evidence to 
conclude that overall susceptibility to diabetes has been increased during last 15 
years. The villages enrolled in this study are more or less representative of an 
average south Indian village, these result clearly foresee the disease burden that 
much of rural south India is going to face.    
  Prior studies have highlighted the escalating problem of diabetes in urban India 
however; high quality information about type2 diabetes in rural areas is scarce. 
Even though longitudinal studies are lacking in India, there is more evidence to 
suggest that prevalence of type 2 diabetes is increasing in rural areas based on cross 
sectional studies. A study on the prevalence of diabetes in the rural population of 
South India was conducted in the year 1990, and the prevalence rate was reported 
to be 2.4%.31. Another study conducted by the Diabetes Research Center (DRC) in 
Chennai, India, reported a prevalence of 5.9% in semi urban areas, which is 
midway between the urban (11.6%) and the rural (2.4%) figures.32The sample 
population resembled rural population for some features, but had access  to certain 
urban facilities. A recent survey in a rural area in 2003 showed indications of the 
transition in the lifestyle of the rural population, and a striking increase in the rate 
of prevalence of diabetes was noted (6.3%).  In a developing area of Andhra 
Pradesh, about 13 per cent of adults aged 30 or above were found to have diabetes 
and another 16 per cent with symptoms of pre-diabetes19  The rapid increase in 
population, increased longevity and high ethnic susceptibility to diabetes, coupled 
 with rapid urbanization and changes from traditional lifestyles, will most likely 
trigger a diabetes epidemic in  the rural India also.  
Analysis of other selected risk factors 
Sex and diabetes 
This study showed that males had more risk for future diabetes than females Global 
diabetes study results  shows that there is a male excess in India (11 vs. 8 million)2 
Age and diabetes 
Univariate analysis showed that as age increased risk of future diabetes also 
increased. After adjusting with other risk factors it was found that age wasn’t 
a significant predictor of future diabetes. 
 The  baseline  study showed that prevalence of diabetes increases with age. The 
DECODA study group26pointed  that the prevalence of diabetes reached its peak  at 60–
69 years of ages followed by a decline at 70–79 years of age in Indian cohorts  and mean  
FPG increased with age and reached a peak at 60–69 years of age then started to decline 
..Analysis of the baseline characteristics of the present study population showed that like 
DECODA study here also  mean FPG increased with age. So one need to examine 
whether age or mean FPG is the real  predictor of future diabetes  
 Baseline blood pressure and diabetes. 
 Univariate analysis and multivariate analysis revealed that hypertension as 
defined by SBP>=140 mm of Hg and DBP>=90mm of Hg at baseline study is 
significantly associated with diabetes (WHO criteria). This finding is in agreement 
with earlier studies done in the west. 
Cholesterol and diabetes 
 The association between baseline cholesterol and diabetes remained even after 
adjusting many other variables. Cholesterol baseline value of 150-200mg/dl in the 
 univariate and above 200mg/dl in the multivariate analysis  showed a strong association. 
Previous longitudinal studies from western countries had similar results and were 
explained in terms of metabolic syndrome. 
BMI and diabetes 
 The strong association between BMI and diabetes remained even after 
adjusting for many other variables. Univariate analysis showed the lower limit of 
BMI for risk of developing diabetes started with the  group of BMI 21-24kg/m2 This 
lower limit of risk remained in the multivariate analysis using  WHO diagnostic 
criteria for diabetes.  
The results of the DECODA study group60 showed that The effect of BMI on 
the age-adjusted prevalence of Type 2 diabetes was modified by ethnicity with 
considerably lower thresholds in Indian  subjects compared to those from the rest of 
Europe. The risk starting at a BMI between 15 and 20 kg/m2 in  Indian populations 
compared to 25 kg/m2 in Europeans.. . Cross sectional studies from South India also 
proved that BMI>=23 kg/m2 associated with risk of diabetes31. This difference 
should be reflected in national and international recommendations regarding 
"optimal" BMI 
Abdominal obesity and diabetes. 
  Multivariate analysis showed that an abdominal circumference of 85cm  or above 
for males and 80cm or above for females is a real predictor of future diabetes. According  
to the  International Diabetes Federation (IDF))  central obesity for south Asian 
population was defined as waist circumference >=90 cm for males and >=80cm 67for 
females . 
 Previous studies from south East Asian countries showed that central adiposity is a real 
risk factor for diabetes and the risk starts a little earlier than western countries30,31  
Excess body fat appears to play a strong role in insulin resistance, but the way the fat is 
distributed is also significant. Weight concentrated around the abdomen and in the upper 
part of the body (apple-shaped) is associated with insulin resistance and diabetes, heart 
 disease, high blood pressure, stroke, and unhealthy cholesterol levels.  Abdominal obesity 
is also common among people in countries where weights tend to be low, such as Asia or 
India.. 
The results showed that, at relatively low abdominal circumference, the Kaniyambadi 
rural cohort experience elevated levels of risks for the future diabetes.. These findings 
points the need to revise the WHO cut-off values for the various indices of obesity and fat 
distribution like BMI and waist circumference. The  present study showed that after 
adjusting all other risk factors  abdominal  obesity at  the baseline survey  had 1-3 times 
risk for getting future diabetes  over a period of   15 years. Clustering of risk factors for 
future type2 diabetes like abdominal obesity, cholesterol, blood pressure and prediabetes 
stage were seen in this study and all can be explained in terms of the  metabolic 
syndrome.22 Symptoms and features are: 
• Fasting hyperglycemia - Diabetes mellitus type 2 or impaired fasting glucose 
• High blood pressure 
• Central obesity also known as visceral adiposity. 
• Elevated triglycerides 
• Decreased HDL cholesterol 
The metabolic syndrome is not benign; it is associated with a substantially elevated 
risk of type 2 diabetes (5-fold) and of cardiovascular disease (CVD) (2–3-fold)22 
The present study couldn’t include HDL and triglycerides for the analysis 
Socioeconomic status and diabetes 
Univariate analysis showed a significant positive association of SES with the type 2 
diabetes.It lost its significance after adjusting with other variables. 
 Chennai Urban population study showed that  subjects belonging to higher socio-
economic status (SES) had  greater prevalence of glucose intolerance compared to 
subjects from lower socioeconomic status.72. This was probably related to the physical 
activity of the low income group (LIG) as most of them were involved in moderate to 
strenuous physical activity at work. Prevalence of diabetes and IGT were significantly 
lower in the LIG than in the high-income group (HIG). The finding of lower prevalence 
of diabetes in the socially deprived urban Indians was in contrast to the positive 
association of diabetes and social deprivation in western countries.71 
Physical activity and diabetes 
The present study showed that even though annual incidence is less in people with high 
physical activity it couldn’t show any significant protective effect both in univariate and 
multivariate analysis. 
A number of selected risk factors at present survey like incidence of blood pressure, BMI, 
abdominal obesity and diabetes   were also studied. But none showed significance for risk 
of developing future diabetes 
The main objective of this study was to find the predictive validity of fasting 
blood glucose in detecting future diabetes in rural south India over a period of 15 years. 
The results  of the study proved that baseline fasting plasma glucose is a real predictor of 
future diabetes .The results of the study also  highlights the importance of  the impaired 
fasting glucose in detecting future type 2 diabetes .After adjusting with all variables  
Selected risk factors at baseline survey  like cholesterol, blood pressure ,body mass 
index,sex and ,waist circumference were significant predictors of diabetes when diabetes 
was defined by  the WHO diagnostic criteria. 
Studies of patients with IGT or IFG had shown success for lifestyle interventions 
in delaying or preventing the development of diabetes.68,69,70There is strong evidence that 
 a structured program of diet and exercise can reduce the risk of progression to type 2 
diabetes in patients with prediabetes. Patients with IFG and IGT should be advised on the 
benefits of modest weight loss, good dietary habits, and regular physical activity. 
The results of the present study points to the urgent need for intervention studies 
in the Kaniyambadi block. With overall development in the Tamilnadu state and specific 
economic developmental inputs by Community Health Department of Christian Medical 
College it is considerable life style changes has increased the diabetic proneness of the 
community. We are  yet to completely control the infectious disease problem in this 
region, this new threat of diabetes epidemic can add considerable disease burden to the 
community. 
. Since diabetes is a disease of slow progression, early detection of the 
intermediate stages  like impaired fasting glucose and impaired glucose tolerance and 
appropriate  intervention  starting at this stage  will definitely decrease the  future burden 
of the disease . 
                
 
 
 
 
 
  
 
 
 
9. SUMMARY AND CONCLUSION 
The objective of this cohort study was to estimate the predictive validity of fasting 
plasma glucose in risk of future type 2 diabetes. Some selected risk factors for future 
diabetes was also studied. The annual incidence of diabetes in the study cohort by ADA 
criteriea FPG>=126mg/dl was studied and by WHO criteria that is either 
FPG>=200mg/dl or OGTT>= 200mg/dl was also studied. This study shows that males 
are at higher risk of developing future diabetes than females. This study also shows that 
age is not a significant predictor of future diabetes as baseline prevalence study has 
shown. After simultaneous adjustments for confounders using multivariale analysis 
baseline fasting plasma glucose remained as a significant predictor of future type 2 
diabetes in a rural population aged 30-60. The risk associated withFPG increases from 
100ml/dl and highest risk is for the group with FPG 110-125 mg/dl. The result of this 
study strongly supported ADA’s concept of impaired fasting glucose.  This study also 
showed that the revised classification of impaired fasting glucose [100 mg/dl-125 mg/dl] 
is applicable for a south Indian rural population aged 30-60 years.  The present study 
calculated projected cumulative incidence of the baseline cohort and it showed at least 
four fold increase in the  burden.of the disease.Other significant predictors were sex, 
 baseline cholesterol >=200 mg/dl and systolic blood preasure >=140mg./dl,diastolic 
blood pressure >=90mg/dl ,BMI>=25kg/m2 and abdominal obesity(male>=85cm and 
female>=80cm.) .Risk factrors like physical activity, socioeconomic statusand age were 
proved as nonsignificant in multivariate analysis. 
 
10 LIMITATIONS 
• As 2hr OGTT was not done in baseline survey it was not possible to compare with 
risk of future type2 diabetes by FPG and future type2 diabetes by 2hrOGTT. 
• All people in eligible cohort were not able to be followed up because of limited 
resources.  Even though total sample size calculated was achieved required sample 
size could not be achieved for subgroupof FPG 110-125 mg/dl  
• The exact point of time at which the participants progressed to diabetes was not found 
since there was no serial follow up of the people in the baseline cohort. So for 
analysis purpose the present study assumed that at exactly half of the follow up period 
conversion of normoglycemia to diabetes stage occurred. 
 
 
 
 
 
 
 
 
 
  
 
 
 
11.RECOMMENDATIONS 
It is necessary to 
• Increase the public health awareness about type2 diabetes.  The study results showed 
that fifteen years cumulative incidence was about four fold higher than  baseline 
prevalence. 
• We should Screen the public for risk factors for diabetes and blood glucose 
investigations should be done on high risk approach. 
• Since most of the risk factors are modifiable, early intervention studies are 
recommended to find out whether progression to type2 diabetes can be prevented at 
an earlier stage.  
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 APPENDIX  -1 
OPERATIONAL DEFINITIONS 
1. Types of house 
Hut – a one-room construction of mud walls with a thatched roof. 
Kutcha – construction with more than one room with mud walls and thatched roof. 
Mixed – a house, which has one or two of the following, cement or mortar used for 
plastering of wall or floor with the tiled roof. 
Pucca – one which is built with a foundation using stone or bricks with mortar and 
cement and having a stone laid roof or tiled roof. 
Mansion – a large house containing more than 5 rooms (excluding kitchen and toilet). 
 
2. OCCUPATION 
I-Agriculture related 
1.1-land owner 
1.2–cultivator owner 
1.3–cultivator tenant 
1.4–cultivator labourer 
II-Non agriculture (general) 
2.1-Business man/factory owner 
2.2-White collar job/clerk/teacher/malaria worker 
2.3-Armed forces/police 
2.4-Skilled labourer/electrician/mechanic/driver 
2.5-Petty business 
2.6-Manual labourers 
2.7-Domestic workers 
2.8-Attender/peon 
  
III-Traditional non-agriculture (rural) 
3.1-Blacksmith 
3.2-Goldsmith 
3.3-Potter 
3.4-Masonry 
3.5-Basket weaving 
3.6-Craft-centre employee 
3.7-Barber 
3.8-Shepherd 
3.9-Dhobi 
IV-Person not employed gainfully 
4.1-House wife  
4.2-House hold work 
V-High prestige-low income 
5.1-PTCHW 
5.2-Balwadi teacher 
5.3-Temple priest 
 
3. SES SCORING 
Education 
No education-0,     Primary (1-5)-1,       Middle (6-8)-2,     High (9-10)-3, 
Higher sec-4,    Above 12th-5 
Land owner :( In wet lands) 
 1 Acre of wet land = 5 acres of dry land. 
No land – 0,      <1 Acre – 1,    1-4 Acre -2,     5-9 Acre -3,     >=10Acre – 4, 
Occupation 
1.4, 2.6, 2.7 – agric labor, Unskilled – 1 
3.1-3.9, 2.7-skilled – 2 
2.5- Small business – 3 
5.1-5.3,2.8- independent profession – 4 
1.1 -1.3 – Cultivator – 5 
2.1 – 2.3 – Govt/Private/Exservice - 6 
4. Physical activity 
1. Sedentry- Retired people, Unemployed, Businessman ECT. 
2. Mild-Clerical jobs, Teachers ECT 
3. Moderate- Peons, Artisans, Postman, Mechanic, Shepherd, Drivers ECT. 
4. Heavy- Farmers, Blacksmith, Manual labours ECT. 
 
 
 
 
 
 
  
 
APPENDIX-2 
STUDY ON TYPE 2 DIABETES MELITUS 
SNO 
 IDNO 
NAME 
HEIGHT (m) 
WEIGH(kg) 
BMI(kg/m2) 
WAIST CIRCUMFERENCE (cm) 
BLOOD PRESSURE(mm of Hg) 
DATE OF SURVEY 
FASTING BLOOD SUGAR(mg/dl) 
2HOUR ORAL GLUCOSE TOLERENCE TEST(mg/dl) 
 
